Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective
- DOI
- 10.1093/ndt/gfac056
- Published
- 2022-03-03
- Container
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ndt/gfac056,
title = {Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective},
author = {Mendy ter Avest and Romy N Bouwmeester and Caroline Duineveld and Kioa L Wijnsma and Elena B Volokhina and Lambertus P W J van den Heuvel and David M Burger and Jack F M Wetzels and Nicole C A J van de Kar and Rob ter Heine and Unknown and E van Kempen and W Altena and E Adang and D J A R Moes and A D van Zuijlen and S P Berger and F J Bemelman and J W van der Heijden and J van de Wetering and A P J de Vries and P van Paasen and J F M Wetzels and J A E van Wijk and A H M Bouts and E M Dorresteijn and V Gracchi and F A P T Horuz Engels and M G Keijzer-Veen and R W G van Rooij and N C A J van de Kar},
year = {2022},
journal = {Nephrology Dialysis Transplantation},
doi = {10.1093/ndt/gfac056},
url = {https://doi.org/10.1093/ndt/gfac056}
}RIS
TY - JOUR TI - Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective AU - Mendy ter Avest AU - Romy N Bouwmeester AU - Caroline Duineveld AU - Kioa L Wijnsma AU - Elena B Volokhina AU - Lambertus P W J van den Heuvel AU - David M Burger AU - Jack F M Wetzels AU - Nicole C A J van de Kar AU - Rob ter Heine AU - Unknown AU - E van Kempen AU - W Altena AU - E Adang AU - D J A R Moes AU - A D van Zuijlen AU - S P Berger AU - F J Bemelman AU - J W van der Heijden AU - J van de Wetering AU - A P J de Vries AU - P van Paasen AU - J F M Wetzels AU - J A E van Wijk AU - A H M Bouts AU - E M Dorresteijn AU - V Gracchi AU - F A P T Horuz Engels AU - M G Keijzer-Veen AU - R W G van Rooij AU - N C A J van de Kar PY - 2022 JO - Nephrology Dialysis Transplantation DO - 10.1093/ndt/gfac056 UR - https://doi.org/10.1093/ndt/gfac056 ER -
APA
Avest, M. T., Bouwmeester, R. N., Duineveld, C., Wijnsma, K. L., Volokhina, E. B., Heuvel, L. P. W. J. V. D., Burger, D. M., Wetzels, J. F. M., Kar, N. C. A. J. V. D., Heine, R. T., Unknown, Kempen, E. V., Altena, W., Adang, E., Moes, D. J. A. R., Zuijlen, A. D. V., Berger, S. P., Bemelman, F. J., Heijden, J. W. V. D., Wetering, J. V. D., Vries, A. P. J. D., Paasen, P. V., Wetzels, J. F. M., Wijk, J. A. E. V., Bouts, A. H. M., Dorresteijn, E. M., Gracchi, V., Engels, F. A. P. T. H., Keijzer-Veen, M. G., Rooij, R. W. G. V., & Kar, N. C. A. J. V. D. (2022). Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac056
Source records
- crossref · retrieved 2026-09-25T00:34:53.758Z